Therefore, a 75‐bp insertion between exons 24 and 25 besides EML4‐ALK rearrangement of resected primary lung cancer after second‐generation ALK‐TKI treatment may reflect a possible resistant mutation. The gene discussed is EML4; the disease is lung carcinoma.